Judge Allows Aredia Plaintiffs To Alter Complaint

Law360, New York (July 12, 2007, 12:00 AM EDT) -- The federal judge presiding over the multidistrict litigation involving bone cancer drugs Aredia and Zometa has given the plaintiffs his blessing to amend their complaint once again. The charge that the medications lead to the painful deterioration of the jawbone, however, remains central to the case.

U.S. Magistrate Judge Joe Brown on Wednesday granted the group's request to alter its product liability complaint against pharmaceutical giant Novartis Corp., after the plaintiffs notified the court that some inaccuracies in the suit had been brought to their attention...
To view the full article, register now.